Skip to main content
Premium Trial:

Request an Annual Quote

Own Merits

There are thousands of new research papers examining the coronavirus, and NPR writes that the sheer volume can make it tricky for scientists and others to sort through and vet.

BMJ's Theo Bloom tells NPR one common approach many people use is to look for names of researchers or institutions on the paper they are familiar with and find trustworthy. However, Bloom adds that this approach can reinforce the "'old boys' network" and discount potentially important coronavirus research coming out of China and Europe from researchers and institutions that might not be as well known to US researchers. 

She cautions against the use of those types of markers to indicate quality. "There are retractions and falsifications from great journals, great institutions, from Nobel laureates and so on," Bloom adds at NPR. "So, it behooves us all to try and move away from who we recognize as good."

Instead, researchers tell NPR that the science should be vetted on its own. McGill University's Jonathan Kimmelman, for instance, describes how he compared one research team's stated plan at to what it reported, finding inconsistencies. "It probably took me something between 15 minutes and 30 minutes to come to [the] conclusion that this paper wasn't worth the time of day," he tells NPR.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.